{"organizations": [], "uuid": "563563ceb341171c48d0fafe6b9a2d2e4b1e3925", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-teva-announces-exclusive-launch-of/brief-teva-announces-exclusive-launch-of-two-strengths-of-a-generic-version-of-solodyn-in-the-united-states-idUSASB0C6GJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-20T18:11:00.000+02:00", "replies_count": 0, "uuid": "563563ceb341171c48d0fafe6b9a2d2e4b1e3925"}, "author": "", "url": "https://www.reuters.com/article/brief-teva-announces-exclusive-launch-of/brief-teva-announces-exclusive-launch-of-two-strengths-of-a-generic-version-of-solodyn-in-the-united-states-idUSASB0C6GJ", "ord_in_thread": 0, "title": "BRIEF-Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States", "locations": [], "entities": {"persons": [], "locations": [{"name": "united states", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "united states reuters staff", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "teva", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 20, 2018 / 4:13 PM / Updated 23 minutes ago BRIEF-Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States Reuters Staff 1 Min Read Feb 20 (Reuters) - Teva Pharmaceutical Industries Ltd: * TEVA ANNOUNCES EXCLUSIVE LAUNCH OF TWO STRENGTHS OF A GENERIC VERSION OF SOLODYN® IN THE UNITED STATES * TEVA - ‍EXCLUSIVE LAUNCH OF 2 STRENGTHS OF GENERIC VERSION OF SOLODYN (MINOCYCLINE HCL) EXTENDED RELEASE TABLETS, 65 AND 115 MG, IN U.S.​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-20T18:11:00.000+02:00", "crawled": "2018-02-20T18:27:43.016+02:00", "highlightTitle": ""}